Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

July 2023

DrugPatentWatch reveals NIH funding for patents

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity

DrugPatentWatch reveals NIH funding for patents Read Post »

Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook

For IP teams, portfolio managers, R&D leads, and institutional investors who need more than an overview. A pharmaceutical patent is

Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook Read Post »

Make Better Decisions

See Plans & Pricing

Recent Posts

The Supply Agreement Clause Nobody Negotiates: What Happens When the Patent Gets Invalidated Early
If Your Patent Database Can’t Answer ‘What Can We Do With This?’ It Isn’t Strategic Intelligence
Your Formulary Committee Is Budgeting Around a Patent Date That’s Already Been Extended Twice
Why Wholesalers Who Overstock Branded Drugs Are Betting Against a Patent Docket They Never Checked
The Specialty Pharmacy Margin Everyone Protects Disappears the Day a Generic Launches

Popular Posts

Biotech’s $400B Problem: The Patent, IP, and Competitive Intelligence Playbook Every Pharma Executive Needs
Understanding Pharmaceutical Competitor Analysis
Pharma Valuation in 2026: Inside the $196 Billion Dealmaking Reset
How to Find a Reputable API Supplier: The Definitive Guide for Pharma IP Teams, R&D Leads, and Institutional Investors
Pharma Valuation, Priced Correctly: The rNPV Math Behind Every Biotech Deal in 2026
China’s Pharmaceutical Innovation Ecosystem: Obstacles, Opportunities, and the IP Architecture Beneath Both
China’s API Chokehold Survived a 100% Tariff. Here’s the Data.
The Top 10 Longest-Running Drug Patents
How Long Do Drug Patents Really Last? The Math Behind 20 Years, 14-Year Caps, and Five-Year Extensions
Addressing the Challenges of Pharmaceutical Distribution in International Markets: Turning Distribution Challenges into Strategic Dominance

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

Sign in or create a free account to read this DrugPatentWatch article

Sign in or create a free account to read this DrugPatentWatch article

EmailEnter your email address